Brain Health Observatory Therapeutic Areas

BHO

Projected Ontario budget savings from reduced long-term care utilization due to a disease-modifying Alzheimer’s treatment

September 14, 2022

BHO

Preparedness of the Brazilian health-care system to provide access to a disease-modifying Alzheimer’s disease treatment

September 5, 2022

BHO

Designing the next-generation clinical carepathway for Alzheimer’s disease

August 19, 2022

BHO

From Trials to Practice: Are We Ready for a Disease-Modifying Treatment?

March 3, 2022

BHO

Projecting the long-term societal value of a disease-modifying treatment for Alzheimer’s disease in the United States

February 9, 2022

BHO

Why would Canada have the longest wait times for an Alzheimer’s treatment among the G7 countries?

January 31, 2022

BHO

Association of Adverse Events in Opioid Addiction Treatment With Quality Measure for Continuity of Pharmacotherapy

January 25, 2022

BHO

Developing a pathway to support the appropriate, affordable, and widespread use of effective Alzheimer’s prevention drugs

January 18, 2022

BHO

Expected wait times for access to a disease-modifying Alzheimer’s treatment in the United States

September 27, 2021